NVCTNuvectis Pharma, Inc.
$20.13+229% 1Y
$20.13
$5.6552 weeks$28.52
The financials
Nuvectis Pharma, Inc. by the numbers
The next results filing is expected around Nov 3, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Operating income | −$7.2M | −$6.6M | n/a |
| Net income | −$7.0M | −$6.3M | n/a |
| Diluted EPS | −$0.30 | −$0.30 | n/a |